EIDX Eidos Therapeutics

About EIDX

BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. The BridgeBio approach combines a traditional focus on drug development with a unique corporate model, allowing rapid translation of early stage science into medicines that treat disease at its source.
50

Neutral Sentiment

How do you feel about EIDX?

Advertisement|Remove ads.